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For their efficient assembly in the endoplasmic reticu-
lum (ER), major histocompatibility complex (MHC) class I
molecules require the specific assembly factors trans-
porter associated with antigen processing (TAP) and
tapasin, as well as generic ER folding factors, includ-
ing the oxidoreductases ERp57 and protein disulfide
isomerase (PDI), and the chaperone calreticulin. TAP
transports peptides from the cytosol into the ER. Tapasin
promotes the assembly of MHC class I molecules with
peptides. The formation of disulfide-linked conjugates
of tapasin with ERp57 is suggested to be crucial for
tapasin function. Important functional roles are also
suggested for the tapasin transmembrane and cytoplas-
mic domains, sites of tapasin interaction with TAP. We
show that interactions of tapasin with both TAP and
ERp57 are correlated with strong MHC class I recruit-
ment and assembly enhancement. The presence of the
transmembrane/cytosolic regions of tapasin is critical
for efficient tapasin–MHC class I binding in interferon-γ-
treated cells, and contributes to an ERp57-independent
mode of MHC class I assembly enhancement. A second
ERp57-dependent mode of tapasin function correlates
with enhanced MHC class I binding to tapasin and cal-
reticulin. We also show that PDI binds to TAP in a
tapasin-independent manner, but forms disulfide-linked
conjugates with soluble tapasin. Thus, full-length tapasin
is important for enhancing recruitment of MHC class I
molecules and increasing specificity of tapasin–ERp57
conjugation. Furthermore, tapasin or the TAP/tapasin
complex has an intrinsic ability to recruit MHC class I
molecules and promote assembly, but also uses generic
folding factors to enhance MHC class I recruitment and
assembly.
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Major histocompatibility complex (MHC) class I molecules
are activating ligands for T-cell receptors of CD8+
T-cells, and the down-modulation of MHC class I
molecules triggers immune recognition by natural killer
cells. Thus, understanding the mechanisms of MHC class I
assembly and cell surface expression is fundamental
to many immune recognition processes. MHC class I
molecules comprise a heavy chain, a light chain and a
short peptide. Assembly of these components occurs
in the endoplasmic reticulum (ER) of cells, and involves
specific assembly factors for transporter associated with
antigen processing (TAP) and tapasin, and generic ER
chaperones. TAP is a critical factor comprising two sub-
units, TAP1 (ABCB2) and TAP2 (ABCB3), that are required
for translocation of peptides from the cytosol into the
ER (reviewed in 1). Tapasin is another critical cofactor
required for the assembly of MHC class I heavy and light
chain heterodimers with peptides (2,3).
Tapasin binds to TAP and increases steady-state levels
of TAP, thereby allowing more peptides to be translo-
cated into the ER (4,5). Truncated tapasin lacking the
transmembrane and cytosolic regions (soluble tapasin)
does not bind to TAP, but is able to bind MHC class I
molecules and induces MHC class I cell surface expres-
sion to some extent (4). A disulfide-linkage is formed
between the luminal cysteine 95 of tapasin and cysteine
57 of ERp57 (6,7). Tapasin–ERp57 binding was shown
to enhance tapasin–MHC class I interactions as well as
the functional activity of tapasin in reconstituted lysates
and in tapasin-deficient cells (8,9). These studies have
led to prevailing models that the transmembrane and
cytosolic domains of tapasin are important for TAP sta-
bilization and function, and that the ER luminal domains
of tapasin are important for MHC class I recruitment and
assembly enhancement. The tapasin–ERp57 conjugate is
suggested to be the functional unit for recruiting MHC
class I molecules and facilitating their peptide binding (8).
However, purified soluble tapasin alone is able to interact
with purified soluble MHC class I in a peptide-regulatable
manner, but unable to induce MHC class I assembly with
peptides (10). Purified soluble tapasin alone when teth-
ered to purified MHC class I molecules via a Fos-Jun
linkage is able to impact the assembly of MHC class I
molecules with peptides (11). Furthermore, recent stud-
ies also suggest a role for the transmembrane/cytosolic
region of tapasin for tapasin–MHC class I binding and for
the functional activity of tapasin (12).
These different findings make it important to further
understand the mechanisms of MHC class I recruitment
to tapasin and of tapasin-mediated enhancement in the
assembly of MHC class I molecules. Toward this end, we
generated tapasin mutants lacking the ERp57 binding site
[tapasin(C95A)], the TAP binding site (soluble tapasin), or
both [soluble tapasin(C95A)]. Functional and interactions
studies with these tapasin mutants provided important
insights into the distinct modes of tapasin functions.
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ERp57 is structurally and functionally related to PDI
which was recently found to be associated with the
TAP complex, and also suggested to be important for
maintaining oxidized forms of TAP-associated MHC
class I heavy chains (13). Some recent studies have
questioned whether PDI is in fact recruited into the
TAP complex (14 and references cited therein), and
previous studies indicated that PDI did not form a
disulfide-linked tapasin conjugate, under conditions where
tapasin–ERp57 conjugates were observable (15). We also
undertook analyses of interactions of PDI with TAP and
tapasin in the context of the different tapasin mutants.
These studies revealed a tapasin-independent mode of
PDI–TAP association, and unexpected insights into the
role of TAP–tapasin binding for enhancing specificity of
tapasin–ERp57 conjugation.
Results
Reduced functional activities of soluble tapasin
and tapasin(C95A) mutants
M553 is a tapasin-deficient human melanoma cell line with
HLA-A2-haplotype loss (16). We examined the effects
of the tapasin(C95A) mutation upon the abilities of full-
length and soluble FLAG-tagged tapasin to induce cell
surface expression of endogenous MHC class I of M553
cells (Figure 1A) and exogenously expressed influenza
hemagglutinin-tagged HLA-A2 (M553/A2) (Figure 1B).
Tapasin, when expressed exogenously, up-regulated MHC
class I cell surface expression in M553 and M555/A2 cells
(Figure 1A,B), as previously described (16). Tapasin also
promoted assembly and ER exit of endogenously and
exogenously expressed MHC class I molecules in M553
cells (data not shown). The soluble tapasin truncation
reduced tapasin’s ability to induce MHC class I surface
expression, consistent with previous findings that TAP
association is required for full function of tapasin (17,18)
(Figure 1A,B). In the context of full-length tapasin, the
C95A mutation also partially impacted tapasin’s ability
to induce endogenous MHC class I surface expression
(Figure 1A) or exogenous influenza hemagglutinin-tagged
HLA-A2 (A2) surface expression (Figure 1B), whereas in
the context of soluble tapasin the C95A mutant had very
low activity (Figure 1A,B). In M553 cells expressing wild-
type soluble and full-length tapasin, class I expression
(total steady-state class I) was enhanced compared
with M553 alone (lacking tapasin) suggesting that wild-
type soluble and full-length tapasin expression stabilized
endogenous MHC class I in M553 cells (Figure 1A, lower
panel, class I blot). Similar tapasin-mediated stabilization
of exogenous class I (A2) was also observed (Figure 1B,
Figure 1: Tapasin truncations and C95A
mutations affect surface expression and
steady-state levels of endogenous and
exogenous MHC class I molecules. A and
B) Upper panels: Histogram showing cell
surface expression of MHC class I in M553
or M553/A2 cells in the presence of the
indicated tapasin constructs. Middle panels:
Bar graphs shows mean fluorescence ratios
of MHC class I expression as assessed
by the W6/32 antibody (A) or anti-HA
antibody (B) in the presence or absence
of the indicated tapasin constructs. FACS
data show average and standard error of
mean of two independent analyses for
(A) and four independent analyses for (B).
Lower panel: Immunoblotting analysis using
antibodies against tapasin and MHC class I
[HC10 for (A) and anti-HA for (B)] of
lysates from cells expressing the indicated
proteins. C) Immunoblotting analysis using
antibody against tapasin of lysates from
HeLa cells and M553 cells expressing full-
length tapasin. D) Immunoblotting analysis
of lysates from M553 cells expressing
soluble tapasin following no treatment or
Endo-H digestion. Soluble tapasin and full-
length tapasin are abbreviated as Sl.Tpn
and Fl.Tpn, respectively. A total of 2 × 106
M553 or M553/A2 cells expressing indicated
tapasin constructs were used per sample in
the FACS analysis.Filled histogram shows
control without primary antibody.
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lower panel, A2 blot). Tapasin expression in M553 cells
was comparable to the endogenous levels observed in
other cell types such as HeLa cells (Figure 1C). The
presence of the FLAG tag increased the molecular weight
of soluble tapasin causing it to migrate very close to full-
length tapasin when analyzed following SDS–PAGE and
immunoblotting (Figure 1A,B, lower panel, tapasin blot).
Under steady-state conditions, soluble tapasin remains
completely Endo-H sensitive, indicating that it is retained
in the ER of M553 cells (Figure 1D).
Tapasin mutations differentially impact binding
to ERp57, MHC class I and calreticulin
Tapasin–ERp57 interaction was suggested to be critical
for tapasin–MHC class I binding in some studies (8,9),
whereas other studies have suggested a critical role for the
transmembrane and cytosolic domains of tapasin in MHC
class I binding (12). To further examine these possibilities,
we undertook various co-immunoprecipitation studies.
Efficient observation of tapasin binding to ERp57 and
MHC class I in M553 cells required the use of a
cross-linker such as dimethyl 3,3’ dithiobispropionimidate
2HCl (DTBP) or a thiol-modifying agent such as methyl
methanethiosulfonate (MMTS). Using DTBP, a cell
permeable cross-linker that was quenched prior to cell
lysis, tapasin–ERp57 interactions were observed, and
were C95-dependent in the context of both full-length and
soluble tapasin as expected (Figure 2A,D). We believe this
is evidence that specific C95-dependent interactions occur
in cells and are not an artifact of interactions induced during
cell lysis in MMTS. In all our binding studies, interferon-γ
(IFN-γ) treatment of cells was also used to up-regulate
TAP and enhance interactions that were potentially TAP-
dependent, and also induce MHC class I expression for
the interaction studies. Under these conditions, both full-
length tapasin–MHC class I complexes were detectable
with significantly higher efficiency than either soluble
tapasin–MHC class I complex, and the C95A mutation
reduced binding to MHC class I in the context of
both full-length and soluble tapasin (Figure 2B,E). The
tapasin–MHC class I binding was observable even in the
context of soluble tapasin(C95A), consistent with our
Figure 2: Tapasin truncations and C95A mutations impact tapasin–ERp57, tapasin–MHC class I and tapasin–calreticulin
interactions. These analyses were conducted following cell treatments with IFN-γ for 48 h (A–G). 1.2–2.4 × 107 cells were treated
with the membrane-permeable cross-linker DTBP immediately prior to lysis. Immunoblotting analysis with anti-tapasin (Pasta-1)
immunoprecipitates or lysates from M553 (A–C), M553/A2 (D–F) or both (G) cells expressing indicated tapasin constructs. Antibodies
specific for tapasin (Tpn), ERp57, calreticulin (CRT) and MHC class I were used in the immunoblotting analyses. Data are representative
of two (A–G) or four (E) independent analyses. The lanes labeled lysate + beads correspond to the background bands obtained when
lysates were immunoprecipitated with protein G beads (no antibody was used) and the lanes labeled antibody alone correspond to the
background bands obtained when antibody was immunoprecipitated with buffer (no cell lysates were used). Ns, indicates non-specific
bands that run above the tapasin or MHC class I heavy chain bands in the anti-tapasin and anti-class I blots.
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previous finding that purified soluble tapasin and MHC
class I are able to interact in the absence of all other
components of the MHC class I assembly complex (10).
However, this interaction is essentially functionally sterile
in cells (Figure 1), as previously observed with the purified
proteins (10).
Calreticulin is a component of MHC class I assembly com-
plex (3), and calreticulin and ERp57 can interact indepen-
dent of other MHC class I assembly components (19). In
addition, tapasin- and ERp57-deficient cells have reduced
abilities to recruit calreticulin into associations with the
MHC class I assembly complex (20,21). Thus, investiga-
tions of the ERp57-dependence of tapasin–calreticulin
binding were relevant. Calreticulin–tapasin binding was
most efficiently detected in the context of full-length wild-
type tapasin, and the C95A mutation reduced binding
efficiency but did not abrogate binding, indicating that cal-
reticulin association with tapasin was linked to ERp57
(Figure 2C,F), particularly in the context of full-length
tapasin. Similar levels of calreticulin–tapasin interactions
were observed when M553 and M553/A2 cells were
compared within the same experiment, indicating that
over-expression of MHC class I did not significantly impact
the efficiency of calreticulin–tapasin binding under the
conditions of the analyses (Figure 2G).
Compositions of TAP complexes are differentially
impacted by tapasin mutations
On the basis of the previous studies (4,9), the transmem-
brane and cytosolic domains of tapasin are expected to be
essential for TAP binding, and C95 of tapasin is expected
to be essential for TAP–ERp57 binding and important
for TAP–MHC class I and TAP–calreticulin binding. To
further examine these requirements for tapasin in bridg-
ing different interactions to TAP in IFN-γ-treated cells,
we undertook co-immunoprecipitation analyses with a
TAP-specific antibody. TAP–tapasin binding was indeed
strictly dependent on the presence of full-length tapasin
(Figure 3A,E). No binding was observed between soluble
tapasin and TAP1 in the anti-TAP1 immunoprecipita-
tions (IPs) (Figure 3A,E), demonstrating the specificities
of the interaction analyses in these assays. ERp57 bind-
ing to TAP1 was also tapasin-dependent, and required
Figure 3: Tapasin truncations and C95A mutations impact the compositions of TAP complexes. The indicated cells were treated
with IFN-γ for 48 h. For the analyses shown in panels E–H, 1.2–2.4 × 107 cells were treated with the membrane-permeable cross-linker
DTBP immediately prior to lysis. The analyses in panels A–D did not use a cross-linker. A–H) Immunoblotting analysis of anti-TAP1
immunoprecipitates or lysates from M553 (A–D) or M553/A2 (E–H) cells expressing indicated tapasin constructs. Antibodies specific
for TAP1, tapasin (Tpn), MHC class I heavy chain, ERp57 and calreticulin (CRT) were used. Data are representative of two (A–H) or
four (F) independent analyses. The lanes labeled lysate + beads correspond to the background bands obtained when lysates were
immunoprecipitated with protein G beads (in the absence of antibody) and the lanes labeled antibody alone correspond to the background
bands obtained when antibody was immunoprecipitated with buffer (no cell lysates were used). Solid lines in panel C indicate lanes that
were cut and pasted from the same blot in order to preserve the order of presentation of lanes. Dashed lines in panel G indicate different
exposures shown for immunoprecipitates and lysates of TAP1 blots from within the same experiment. Ns indicates antibody-derived
non-specific bands that run above the tapasin and class I bands in blots with anti-tapasin, anti-class I and below the ERp57 band in blots
with anti-ERp57 (IP lanes only).
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the presence of C95 of tapasin (Figure 3B,F). Further-
more, calreticulin binding to TAP was ERp57-linked
(Figure 3C,G). Finally, MHC class I association with TAP
was also strongly tapasin-dependent, but at best only
partly impacted by the C95A mutation (Figure 3D,H),
consistent with the findings of Figure 2. TAP1 interac-
tions with indicated proteins were stable, and interactions
were detectable both in the absence (Figure 3A–D) and
in the presence of cross-linker (Figure 3E–H). Together,
these findings indicate that ERp57 association with TAP
is dependent on tapasin and requires an intact tapasin
C95, that calreticulin association with TAP is ERp57-
linked, and that MHC class I association with TAP is
strongly tapasin-dependent, but only partly linked to C95
of tapasin.
MHC class I-calreticulin binding is significantly
impacted by tapasin(C95A) mutations
The binding studies of Figure 2 undertaken with an anti-
tapasin antibody revealed that soluble tapasin truncation
impaired tapasin–MHC class I binding more significantly
than the tapasin(C95A) mutation, indicating that the
tapasin transmembrane/cytosolic regions indirectly or
directly stabilized tapasin–MHC class I binding. Similar
results were obtained when the immunoprecipitation
analyses were undertaken with an anti-MHC class I (HC-
10) antibody (Figure 4A,B). HC-10 was used as it has
previously been shown to efficiently detect tapasin–MHC
class I complexes (22). ERp57 binding to MHC class I
was readily detectable in the context of full-length
tapasin (Figure 4A,B), and weakly detectable in the
context of soluble tapasin (Figure 4B) likely reflecting
the indirect tapasin-mediated association between ERp57
and MHC class I heavy chains. Despite weaker MHC
class I binding by soluble tapasin compared with the
full-length tapasin(C95A) mutant, soluble tapasin was
able to induce MHC class I to a level similar to or
greater than that induced by full-length tapasin(C95A),
both in the absence of IFN-γ (Figure 1) and in the
presence of IFN-γ (Figure 4C). Functional activity of soluble
tapasin correlated with its ability to more efficiently
recruit calreticulin into association with MHC class I
molecules, compared with tapasin(C95A) (Figure 4A,B).
Calreticulin binding to MHC class I was detected most
efficiently in the presence of full-length tapasin, and
additionally, calreticulin binding was enhanced in the
context of wild-type and soluble tapasin compared
with either C95A mutant (Figure 4A,B). Together, these
results suggest that the ability to recruit calreticulin
into associations with MHC class I molecules in an
ERp57-dependent manner may underlie the observed
functional activity of soluble tapasin. ERp57 association
with tapasin brings calreticulin into proximity with MHC
class I, which may be related to the enhancements in
steady-state MHC class I in cell lysates in the context
of full-length or soluble tapasin (Figure 1A,B, lower
panels).
Tapasin(C95A) facilitates assembly of MHC class I
independent of its functions in TAP stabilization
Pulse chase and Endo-H digestion analyses showed that,
in cells lacking tapasin, MHC class I molecules were
retained in the ER and did not mature even after 120 min.
In contrast, in the presence of full-length tapasin(C95A),
maturation of MHC class I molecules was accelerated,
indicating that tapasin(C95A) actively promoted assembly
of MHC class I molecules and their ER exit (Figure 5A).
Use of wild-type tapasin further enhanced maturation
of MHC class I heavy chains (data not shown). The
ability of full-length tapasin(C95A) to induce MHC class I
assembly and cell surface expression (Figures 1 and 5A)
could be related to tapasin(C95A)-mediated induction
of TAP steady-state levels (4,5), an intrinsic assembly
promoting function of tapasin(C95A), or tapasin(C95A)-
dependent tethering of MHC class I molecules into a
physical association with TAP. To further examine the first
possibility, we compared the effects of IFN-γ treatment of
M553 cells upon the cell surface expression of MHC
class I in M553 cells and in M553 cells expressing
full-length tapasin(C95A) (Figure 5B). IFN-γ up-regulated
MHC class I cell surface expression in both cells with a
more significant effect being observed in the presence
of full-length tapasin(C95A) (Figure 5B). Comparison of
steady-state levels of TAP and MHC class I in IFN-γ-
treated cells or tapasin(C95A)-expressing cells revealed
that under the conditions of the analyses, IFN-γ treatment
had a much more profound effect on steady-state levels
of TAP1 and MHC class I, compared with that induced
by tapasin(C95A) expression (Figure 5C,D). In addition,
higher levels of TAP1/TAP2 complexes were induced by
IFN-γ-treatment, as assessed by immunoprecipitations
with anti-TAP1, followed by immunoblotting analyses for
TAP2 (Figure 5D).
Despite the stronger induction of active TAP complexes
and MHC class I molecules in IFN-γ-treated M553 cells,
cell surface MHC class I expression was consistently
lower than that induced by tapasin(C95A), arguing that
the mechanism of tapasin(C95A) function did not relate
to its ability to stabilize TAP complexes per se. Rather,
the functional activity of full-length tapasin(C95A) relates
either to its intrinsic ability to bind MHC class I and
promote peptide loading of MHC class I, or to its ability
to induce a physical association between MHC class I and
the TAP complex.
PDI associates with TAP in a tapasin-independent
manner
PDI has previously been shown to be associate with
TAP (13), but the tapasin dependence of this interaction
is not well-characterized. We examined the interactions
of PDI with TAP, in the context of the different tapasin
mutations. In contrast to the ERp57–TAP1 interaction
which was completely dependent on the presence of
tapasin (Figure 3B,F), PDI interaction with TAP was
readily detected in the presence of both soluble tapasin
constructs, indicating a tapasin-independent TAP–PDI
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Figure 4: Tapasin truncations and C95A mutations impact MHC class I–tapasin and MHC class I–calreticulin interactions. These
analyses were conducted following cell treatments with IFN-γ for 48 h. A total of 1.2–2.4 × 107 cells were treated with the membrane-
permeable cross-linker DTBP immediately prior to lysis. Immunoblotting analysis with anti-MHC class I (HC10) of immunoprecipitates or
lysates from M553 (A) or M553/A2 (B) cells expressing indicated tapasin constructs. Samples for all panels of (A) and (B) were derived
from the same immunoprecipitation experiment, respectively, and thus a single MHC class I panel is shown for each. Antibodies specific
for MHC class I, tapasin (Tpn), ERp57 and calreticulin (CRT) were used in the immunoblotting analyses. C) Histograms showing cell
surface expression of MHC class I in M553 or M553 cells expressing soluble tapasin or full-length tapasin(C95A) following treatment
with IFN-γ (500 IU) for 48 h (conditions similar to those under which binding studies were undertaken). Filled histogram shows control
staining without primary antibody. Data are representative of one (C) or at least two independent analyses for each panel of (A) and (B).
The lanes labeled lysate + beads correspond to the background bands obtained when lysates were immunoprecipitated with protein G
beads (no antibody was used) and the lanes labeled antibody alone correspond to the background bands obtained when antibody was
immunoprecipitated with buffer (no cell lysates were used). Ns, indicates non-specific bands.
interaction (Figure 6A,B). This result was confirmed in
tapasin-deficient M553 cells (Figure 6C). In fact, the
absence of tapasin in association with TAP appeared to
enhance PDI–TAP associations (Figure 6A,C). TAP1–PDI
interactions were also verified in other human cell types
with an intact MHC class I assembly complex, such as
HeLa cells (Figure 6D) and the TAP1-deficient SK-mel-19
cells that express TAP1 exogenously (data not shown).
The soluble tapasin truncation induces tapasin–PDI
conjugation
Both PDI and ERp57 are associated with TAP (Figures 3
and 6), but tapasin conjugate formation is reported to
be specifically induced with ERp57 (15). We re-examined
whether PDI is able to form disulfide-linked conjugates
with the tapasin constructs used in this study. For these
analyses, IFN-γ-treated cells were lysed in the presence
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Figure 5: The tapasin(C95A) mutant induces MHC class I assembly independent of an effect on TAP stabilization. A) Left panel:
M553 or full-length tapasin(C95A) expressing M553 cells were metabolically labeled for 10 min and chased for the indicated times in fresh
media. Lysates were immunoprecipitated with W6/32, then digested with Endo-H or left undigested and analyzed by SDS–PAGE and
phosphorimaging analyses. Right panel: The Endo-H resistant MHC class I heavy chain (HC) bands in above gels were quantified using
IMAGEQUANT and plotted as a percentage of Endo-H resistant HC. Data are representative of two independent analyses. B) Histograms
showing cell surface expression of MHC class I in M553 or M553 cells expressing full-length tapasin(C95A) following no treatment
or following incubation with IFN-γ (500 IU) for 20 h. C) Immunoblotting analysis using HC10 of indicated amounts of total cell lysates
from IFN-γ-treated M553 cells or tapasin(C95A)-expressing M553 cells. D) Immunoblotting analysis of anti-TAP1 immunoprecipitates of
IFN-γ-treated or untreated M553 and tapasin(C95A)-expressing cells. Antibodies specific for TAP1 and TAP2 were used.
of MMTS (without cross-linker), and immunoblotting
analyses of lysates or anti-tapasin immunoprecipitates
were undertaken following SDS–PAGE under reducing or
non-reducing conditions.
Although the major ERp57 conjugate observable in cell
lysates corresponded to the size of the tapasin–ERp57
conjugate (Figure 7B, lanes 6 and 8), several PDI
conjugates were observable (Figure 7C, lanes 6 and 8),
suggesting that mixed disulfides between PDI and cellular
proteins are more stable or more numerous than those
with ERp57. That tapasin is a uniquely detectable cellular
substrate of ERp57 has previously been documented, and
the stable disulfide-linkage between tapasin and ERp57
is attributed to an additional non-covalent interaction
between the proteins (15). In the absence of chemical
cross-linkers (not used to derive the data of Figure 7)
or trapping mutants of ERp57, mixed disulfide formation
with ERp57 is previously only reported in the context of
tapasin (15) or viral glycoproteins (23).
In immunoprecipitations with the tapasin-specific anti-
body (Pasta-1) (6), as expected, conjugates of 110 kDa
were observed under non-reducing conditions with both
full-length and soluble tapasin, and were detectable in
immunoblotting analyses with anti-tapasin as well as
anti-ERp57 (Figures 7A,B). These conjugates were C95-
dependent (data not shown). In addition, a PDI conjugate
of 110 kDa was observed in immunoprecipitates from
cells expressing soluble tapasin (Figure 7C, lane 1). A
much weaker signal for PDI was obtained under reducing
conditions, indicating that the anti-PDI antibody preferen-
tially detects the conjugated form of PDI (Figure 7C, lane 1
compared with lane 2) (this band is more readily detectable
in longer exposures of the PDI blot; data not shown).
The PDI conjugate of 110 kDa was undetectable or very
weak in the context of full-length tapasin (Figure 7C,
lane 1 compared with lane 3), consistent with the pre-
vious findings that full-length tapasin PDI conjugates are
not readily detectable (15). The 110 kDa PDI conjugate
in the context of soluble tapasin was not observed in
Pasta-1 immunoprecipitates of cells expressing soluble or
full-length tapasin(C95A) (data not shown).
To further characterize whether PDI did form conjugates
with soluble tapasin, and to quantify the extent of
conjugate formation, elution profiles of soluble tapasin
and soluble tapasin(C95A) were compared following lysis
of the corresponding M553 cells in MMTS (without
cross-linker), anti-FLAG-based purifications of soluble
tapasin and associated proteins, and further gel filtration-
based separation of free tapasin or its conjugates.
Relevant fractions were analyzed by reducing (Figure 8A,
left panels) or non-reducing (Figure 8A, right panels)
SDS–PAGE and immunoblotting analyses for tapasin,
ERp57 and PDI. Soluble tapasin was indeed in conjugate
with both ERp57 and PDI in fractions B2–C2, and
fractions C3–C5 contained majority of free tapasin
(Figure 8A). Bands corresponding to a tri-molecular
complexes (Tapasin–ERp57–PDI) were not visualized
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Figure 6: Tapasin-independent association of PDI with TAP. The indicated cells were treated with IFN-γ for 48 h. For panel (B),
cells were treated with the membrane-permeable cross-linker DTBP immediately prior to lysis, and the analyses of panels (A), (C) and
(D) were undertaken without cross-linker treatment. A and B) Immunoblotting analysis of anti-TAP1 immunoprecipitates or lysates from
M553 (A) or M553/A2 cells (B) expressing indicated tapasin constructs. C) Immunoblotting analysis of anti-TAP1 immunoprecipitates
or lysates from parent M553 cells lacking tapasin expression (No Tpn) or M553 cells expressing full-length tapasin(C95A) as indicated.
D) Immunoblotting analysis of anti-TAP1 immunoprecipitates or lysates from HeLa cells. Antibodies specific for TAP1, PDI were used
in the immunoblots. Data are representative of one (C) or two (A, B and D) independent analyses. The lanes labeled lysate + beads
correspond to the background bands obtained when lysates were immunoprecipitated with protein G beads and the lanes labeled
antibody alone correspond to the background bands obtained when antibody was immunoprecipitated with buffer (no cell lysates were
used). Ns indicate non-specific antibody-derived band that runs above the tapasin band or a non-specific band that runs below the TAP1
band.
in the non-reducing gels (Figure 8A), suggesting that
only heterodimers of soluble tapasin–ERp57 and soluble
tapasin–PDI were present. Although weak signals for
a few higher molecular weight band above 110 kDa
were detected in the ERp57 blots (Figure 8A, fractions
B1–C1), these bands were absent in the PDI blots
suggesting that they do not represent a tri-molecular
complex between tapasin–ERp57–PDI. The identity of
these higher molecular weight bands in the ERp57 blot
is unknown. Neither ERp57 nor PDI was visualized in
eluates from cells expressing soluble tapasin(C95A) (data
not shown), confirming that both conjugates with tapasin
were C95-dependent. These findings suggest that PDI-
soluble tapasin conjugates are unlikely to be folding
intermediates, but rather represent a deviation from the
specificity of tapasin conjugation to ERp57.
Soluble tapasin purified from lysates of M553 cells was
mainly observed to migrate at the expected position
for tapasin–ERp57 or tapasin–PDI conjugate (Figure 8A,
fractions B2–C2) or tapasin monomer (Figure 8A, fractions
C3–C5) and only a small amount was observed in the void
volume of the column (Figure 8A, fractions B12–B11).
Soluble tapasin(C95A) migrated at the expected position
of monomer, and only a small fraction was present in
the column void volume (data not shown). Thus, at the
levels expressed in M553 cells, neither soluble tapasin nor
soluble tapasin(C95A) derived from cell lysates appeared
to be significantly aggregated.
The relative amounts of PDI and ERp57 that were
associated with soluble tapasin were quantified by
two different methods. Fractions containing conjugates
were pooled following the gel filtration chromatography,
concentrated, separated by SDS–PAGE and visualized
by Coomassie staining (Figure 8B). Mass spectrometric
analyses of band 1 yielded several proteins including
ERp72 and GRp78. Mass spectrometric analysis of band 2
yielded ERp57 and PDI as the two most abundant
proteins. The averaged intensity of the 10 most abundant
ERp57 peptides was 3.2 × 107, 7.5-fold higher than
the averaged intensity of the 10 most abundant PDI
peptides (4.2 × 106) (Figure S1). This corresponds to PDI
representation at a level of 13.3% relative to ERp57. Mass
spectrometric quantifications of the relative abundance of
ERp57 and PDI were verified by the titration of tapasin
conjugates against known amounts of purified ERp57
and PDI in immunoblotting analyses (Figure 8C). Band
intensities of the purified PDI and ERp57 standards
were plotted as a function of protein concentration,
linearly fitted, and the relative concentration of each
protein in the conjugates calculated. These analyses
suggested PDI representation at a level of 12% relative
to ERp57. Together, these analyses indicate that although
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Figure 7: Soluble tapasin truncation induces tapasin–PDI
conjugation. M553 cells expressing different tapasin constructs
were treated with IFN-γ and lysed in the presence of MMTS
(no cross-linker) and immunoprecipitated with Pasta-1 to study
tapasin conjugates with ERp57 and PDI. A–C) Following lysis in
the presence of MMTS, Pasta-1 immunoprecipitates or lysates
from M553 cells expressing the indicated tapasin constructs were
analyzed by immunoblotting, using antibodies specific for tapasin,
ERp57 and PDI. Arrows indicate the migration positions of DTT-
sensitive bands (conjugates) of approximately 110 kDa. Proteins
were separated by reducing (+DTT) and non-reducing (−DTT)
SDS–PAGE as indicated, prior to immunoblotting analyses.
Non-specific antibody-derived bands that migrate below the
tapasin, ERp57 and PDI bands in the corresponding blots are
indicated by ns.
soluble tapasin is preferentially associated with ERp57,
conjugation to PDI is observable at a level that is not
insignificant.
Heterologous expression of soluble human tapasin
induces associations with several endogenous
oxidoreductases, and aggregation of secreted
but not intracellular versions
We previously reported that purification of soluble tapasin
from supernatants of CHO cells over-expressing solu-
ble human tapasin and cultured at 37◦C yielded protein
that was largely aggregated (Figure 9A, dashed chro-
matogram). Aggregation could be suppressed by culturing
the cells at 30◦C (10). Surprisingly, soluble tapasin puri-
fied from lysates of the CHO cells cultured at 37◦C
and lysed in the presence of MMTS yielded two major
peaks (Figure 9A, solid chromatogram), corresponding to
tapasin–oxidoreductase conjugates (peak 2, Figure 9B) or
free tapasin (peak 3, Figure 9B), rather than aggregated
protein in the void volume (peak 1, Figure 9A). SDS–PAGE
analyses of proteins present in peak 2 revealed the pres-
ence of several protein bands in addition to tapasin. Mass
spectrometric analyses of bands from peak 2 indicated the
presence of peptides corresponding to both ERp57 and
PDI, as well as those corresponding to GRP78 and ERp72.
The ERp57/PDI bands were partially displaced (Figure 9B,
peak 2, lane 1 compared with lane 2) when the peak
was analyzed following soluble tapasin purification from
lysates of CHO cells co-expressing soluble tapasin and
human ERp57 lacking an ER retention motif (Figure 9C,D).
Regardless of human ERp57 co-expression, cell lysate-
derived soluble tapasin was present as conjugates or free
tapasin monomers, whereas the cell supernatant-derived
soluble tapasin was largely aggregated (Figure 9A,D). In
the absence of human ERp57 co-expression, soluble
tapasin associated with endogenous hamster cell-derived
oxidoreductases and chaperones, and some of the inter-
actions persisted despite human ERp57 co-expression.
Thus, ER–lumenal interactions were critical for inhibi-
tion of soluble tapasin aggregation, and soluble tapasin
formed conjugates with several oxidoreductases in ham-
ster cells.
ERp57 representation correlates with calreticulin
recruitment to purified soluble tapasin conjugates
To further study the effect of ERp57 on calreticulin
recruitment to tapasin, we isolated tapasin from lysates of
CHO cells expressing human tapasin alone or human
tapasin and ERp57 (Figure 9E). CHO cells expressing
tapasin alone were lysed in the presence and in the
absence of MMTS, whereas CHO cells expressing
both human tapasin and human ERp57 were lysed in
the presence of MMTS. The three sets of purified
proteins were analyzed by immunoblotting analyses with
antibodies directed against tapasin, ERp57 and PDI. ERp57
representation in eluates from the anti-FLAG column
correlated with human ERp57 co-expression, as well as
the presence of MMTS during cell lyses (Figure 9E, ERp57
blot, lanes 7–9 compared with lanes 1–6). Conversely,
human ERp57 co-expression reduced PDI association
with tapasin (Figure 9E, PDI blot, lanes 7–9 compared
with lanes 4–6). In the absence of MMTS during lysis,
recovery of both ERp57 and PDI were relatively inefficient
or not observable (Figure 9E, ERp57 and PDI blots, lanes
1–3 compared with lanes 4–9). The purified protein
preparations or BSA were immobilized in 96-well micro-
titration plates, and calreticulin binding to each protein or
BSA was compared by enzyme-linked immunosorbent
assay (ELISA) (Figure 9F). Calreticulin showed more
binding to each tapasin preparation compared with the
control protein BSA (Figure 9F). The preparation that had
the highest level of ERp57 representation displayed the
strongest binding to calreticulin (Figure 9F). Thus, in these
in vitro binding assays as in cells, ERp57 binding to tapasin
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Figure 8: PDI forms C95-dependent conjugates with soluble tapasin at reduced levels compared with ERp57. A total of 4.8 × 107
M553/soluble tapasin cells were lysed in the presence of MMTS (no cross-linker) and immunoprecipitated with anti-FLAG beads to study
tapasin interaction with ERp57 and PDI by gel filtration analysis. A) Gel filtration-based separation of proteins derived from M553/soluble
tapasin following lysis in MMTS, and anti-FLAG-based affinity purification of soluble tapasin. Fractions were analyzed for the presence of
tapasin (Tpn), PDI and ERp57 by immunoblotting analyses, following SDS–PAGE under reducing (left panels) or non-reducing conditions
(right panels). B and C) Following gel filtration and pooling/concentration of fractions containing conjugates, proteins were resolved by
SDS–PAGE, Coomassie stained, and indicated bands 1 and 2 were subjected to mass spectrometric analyses (B) or titrated against
indicated concentrations of purified PDI (C, top panel) and ERp57 (C, Lower panel) in immunoblotting analyses. For (B), proteins identified
by mass spectroscopic analyses in bands 1 and 2 and the number of peptides identified for each protein are indicated. For (C), band
intensities were quantified by IMAGEQUANT and plotted as a function of PDI or ERp57 concentration. Linear regression analyses and
interpolation from the standard curves allowed estimation of protein amounts in the conjugates. On the basis of these analyses, 5 μL
conjugate is estimated to contain 75.3 ng ERp57 and 9.1 ng PDI.
enhances the recruitment of calreticulin. As per the data
of Figure 4A,B, it appears that the ERp57-associated form
of calreticulin must also be able to interact with tapasin-
associated MHC class I. It is possible that this binding
contributes to the observed enhancement in stability
of the tapasin–MHC class complex (Figure 4A,B) in the
context of tapasin–ERp57 complexes.
Discussion
The studies described here demonstrate that weak
intrinsic interactions between the lumenal domains of
tapasin and MHC class I are strongly enhanced by the
presence of the transmembrane and cytosolic domains
of tapasin, and also enhanced by tapasin–ERp57 binding
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Figure 9: Purification of different tapasin conjugates from CHO cells and their use in calreticulin binding studies. A and D) Gel
filtration chromatograms of soluble tapasin purified from supernatants (dotted lines) or lysates of MMTS-treated (solid lines) CHO cells
expressing soluble tapasin alone (A) or soluble tapasin and ERp57 (D). Peaks corresponding to gel filtration column void volume (peak 1),
tapasin-oxidoreductase conjugates (peak 2) and free tapasin (peak 3) are indicated by arrows. B) Fractions corresponding to the peaks 2
and 3 of the cell lysate-based chromatograms shown in (A) and (D) were analyzed by SDS–PAGE and Coomassie Blue staining. Arrows
indicate proteins identified by mass spectroscopic analyses of the peak 2 fractions from CHO cells expressing soluble tapasin, and the
number of peptides identified for each protein. C) Metabolic labeling, immunoprecipitation (with indicated antibodies), SDS–PAGE and
phosphorimaging analyses of supernatants from CHO cells expressing soluble tapasin and ERp57 or soluble tapasin alone, to indicate
that both tapasin and ERp57 or tapasin alone were expressed in the supernatants. Solid line in panel (C) indicates a lane that was cut and
pasted from a different gel within the same experiment. E) Immunoblot analysis of purified tapasin proteins, with antibodies directed
against tapasin, ERp57 and PDI as indicated. Lanes 1–3, tapasin purified from CHO–tapasin cells lysed in the absence of MMTS. Lanes
4–6, tapasin purified from CHO–tapasin cells lysed in the presence of MMTS. Lanes 7–9, tapasin purified from CHO–tapasin–human
ERp57 cells lysed in the presence of MMTS. Solid lines indicate lanes that were cut and pasted from the same blots. F) 96-well ELISA
plates were coated overnight with 1–2 μg of indicated tapasin proteins or BSA as control, and binding to purified calreticulin was
analyzed by ELISA. All incubation and wash steps were undertaken in the presence of 0.5 mM CaCl2. Absorbance values obtained from
duplicate readings were used to plot the graph. The data is average of two independent analyses.
(Figures 2 and 4). The inability to recruit ERp57 strongly
impairs the functional activity of soluble tapasin(C95A),
which is a weak inducer of MHC class I assembly
(Figure 1). Although the C95A mutation also reduces the
functional activity of full-length tapasin, significant ERp57
binding-independent functional activity is measurable with
full-length tapasin(C95A), which is not strongly correlated
with tapasin-mediated stabilization of TAP (Figures 1 and
5). The tapasin(C95A) mutation also impacts the efficiency
of calreticulin recruitment to MHC class I molecules
(Figure 4). Although ERp57 and calreticulin binding to
TAP are strongly dependent on or linked to tapasin(C95),
PDI association with TAP is tapasin-independent, and in
fact association appears to be enhanced by the absence
of tapasin or a fully functional tapasin molecule. These
findings indicate distinct modes of binding and distinct
functions for ERp57 and PDI within MHC class I assembly
complexes. Significant C95-dependent conjugation of PDI
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to tapasin is only detectable in the context of soluble
tapasin, studies that point to the importance of full-length
tapasin for enhancing specificity of interactions within
MHC class I assembly complexes.
The panel of mutants described here was also character-
ized in a recent report from the Cresswell laboratory (24),
published while this manuscript was under revision.
Although the two studies come to similar conclusions
about the importance of both tapasin–ERp57 binding and
the transmembrane/cytosolic regions of tapasin in its inter-
actions with MHC class I and functional activities, there
are some notable differences between the studies. Our
studies in M553 cells suggest that the deletion of the
transmembrane/cytosolic domains of tapasin had a more
significant impact on the efficiency of tapasin–MHC class I
binding than did ERp57 conjugation to tapasin (Figures 2
and 4). Immunoprecipitations with the anti-tapasin anti-
body by the Cresswell laboratory suggested a more critical
role for tapasin–ERp57 binding in HLA-B*4402 recruit-
ment to tapasin, following analyses of various tapasin
mutants in 721.220/HLA-B*4402 cells (24). In addition,
despite the lower efficiency of soluble tapasin–class I
complex formation, we were able to detect complexes
between soluble tapasin(C95A) and MHC class I heavy
chains (Figures 2 and 4), whereas these complexes were
not detectable in the other study (24). The observed differ-
ences may relate to the use of IFN-γ in our assays, which
upregulates TAP as well as MHC class I subunits, promot-
ing several of the interactions that are dependent on one or
both of these proteins. TAP expression levels are very rel-
evant to interactions mediated by full-length tapasin, and
thus analyses under conditions where TAP expression is
not limiting are important. It is alternatively possible that
there are allele-specific or other cell type-specific differ-
ences in requirements of ERp57 associations versus the
tapasin transmembrane/cytoplasmic domains for efficient
tapasin–MHC class I binding. Our analyses examined
tapasin binding to endogenously expressed MHC class I
allotypes of M553 cells, which include HLA-A28, HLA-
B*5701 and HLA-B*5001 (16). The Cresswell laboratory
study examined interactions of exogenously expressed
HLA-B*4402 in 721.220 cells which lack endogenous
HLA-A and HLA-B, but express an endogenous HLA-C.
It is possible that binding of tapasin to HLA-B*4402, a
highly tapasin-dependent allotype (25), has more stringent
requirements for accessory ER chaperones.
Our data indicate that tapasin promotes MHC class I
assembly by two major mechanisms, involving (i) an
ERp57-independent mode of tapasin function that requires
the transmembrane and cytosolic domains of tapasin and
involves associations with TAP (Figure 10A) and (ii) an
ERp57-dependent mode of tapasin function requiring the
ER luminal domains of tapasin and associations with
calreticulin (Figure 10B). The ERp57-independent mode
of tapasin function may involve the editing functions
of tapasin which optimizes its peptide repertoire, as
suggested using Fos-Jun tethered tapasin–MHC class I
complexes (11). Furthermore, localization of MHC class I
in the vicinity of the peptide source, TAP, could account
for the ERp57-independent activity of tapasin. In some
species such as chicken, which lack the counterpart of
C95, the ERp57-independent mode of tapasin function
may be the sole mechanism of tapasin function (26).
Importantly, although the ERp57-independent mode of
function requires the transmembrane and cytosolic
domains of tapasin (Figure 1), the role of these domains
Figure 10: Two modes of tapasin function. A) (left) ERp57-independent mode of tapasin function. Studies with the tapasin(C95A)
mutant indicate that tapasin is able to bind MHC class I molecules, and promote assembly of MHC class I molecules, directly and/or
via localization of MHC class I in the vicinity of the TAP transporter. In IFN-γ-treated cells, the C95A mutation reduced the efficiency
of tapasin–MHC class I binding compared with wild-type tapasin, but to a smaller extent than that induced by the soluble tapasin
truncation. B) (middle): Combining both modes of tapasin function (A and C) contributes to strong binding interactions and function in
the context of wild-type tapasin. PDI associates with TAP in a tapasin-independent manner, and may function as an initial acceptor for
TAP-translocated peptides and/or promote degradation of unassembled TAP complex components. C) (right): ERp57-dependent mode
of tapasin function. ERp57 binding to tapasin via C95 promotes assembly of MHC class I molecules directly and/or via the stabilization
of calreticulin–MHC class I interaction. This activity of tapasin is observed with a soluble form of tapasin that is unable to associate with
TAP, even though removal of the transmembrane and cytosolic domains of tapasin markedly destabilizes tapasin–MHC class I binding.
Removal of the transmembrane and cytosolic domains of tapasin also induces C95-dependent conjugation of soluble tapasin with PDI.
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extends beyond the previously suggested functions for
these domains in TAP stabilization (4) (Figures 2, 4 and 5).
Tapasin-dependent recruitment of ERp57 enhanced the
ability of human tapasin to mediate MHC class I assembly
(Figure 1), even under conditions where tapasin–MHC
class I interactions were relatively weak (soluble tapasin;
Figures 2 and 4). ERp57 and calreticulin interact outside
of the MHC class I assembly complex (19), and higher
representation of ERp57 in conjugation with purified
tapasin correlated with increased calreticulin binding
in vitro (Figure 9F). Tapasin-C95-mediated recruitment
of ERp57 and enhanced recruitment of calreticulin
contributed to enhanced calreticulin–MHC class I binding
and increased stabilities of MHC class I heavy chains
(Figures 1A,B, 2 and 4). Thus, calreticulin is likely an
important player in the ERp57-dependent functional
activity of tapasin, but further studies are needed to
understand how calreticulin interacts with MHC class I
and tapasin, and the extent of its contribution to
the functional activity of tapasin. It is widely believed
that binding monoglucosylated glycans is sufficient to
recruit calreticulin to substrates. However, the findings
reported here indicate that multiple tapasin-dependent
interactions rather than glycan binding alone contribute
to efficient recruitment of calreticulin to the MHC
class I assembly complex. Further understanding of the
mechanisms of calreticulin recruitment into the MHC
class I assembly complex will allow insights into whether
similar mechanisms could be used to promote the
recruitment of ER chaperones to enhance the assembly
of other multiprotein complexes, particularly of viruses.
The recent crystal structure analysis of a soluble
tapasin–ERp57 heterodimer showed that both catalytic
domains of ERp57 (a and a’ domain) are involved in tapasin
binding (7). ERp57 residues involved in binding to tapasin
are conserved in PDI (7). Specificity of tapasin–ERp57
heterodimer formation was attributed to differences in
inter-domain orientations between different PDI family
members. A shorter distance was noted between Cα
atoms of C57 and C406 of ERp57 in the tapasin–ERp57
heterodimer (7), compared with counterpart PDI residues
in the yeast PDI structure which was crystallized as free
protein rather than in a substrate-conjugated form (27).
Our studies indicate that soluble tapasin per se is not fully
specific for ERp57 conjugation as conjugates between
soluble tapasin and PDI were also readily detectable,
although at a level approximately 7.5-fold lower than that
of ERp57 (Figures 7 and 8 and Figure S1).
How might TAP binding inhibit tapasin–PDI binding
and promote tapasin–ERp57 interaction specificity?
Cooperative interactions that stabilize the heptameric
complexes involving TAP1/TAP2/tapasin/MHC class I/
calreticulin/ERp57 via multimodal binding between the
different components must impose a strong structural
constraint on the complete complex, which is absent in
the corresponding soluble tapasin complexes. The lack
of complex stability in soluble tapasin complexes is likely
directly responsible for the reduction in oxidoreductase
conjugation specificity. Thus, structural constraints of the
complete MHC class I assembly complex contribute to
the specificity of tapasin–ERp57 binding.
We show that PDI is likely a bona fide component of the
TAP complex not by its ability to conjugate with tapasin
but rather by its ability to bind to TAP (Figure 6). TAP-
associated PDI has been implicated in the maintenance
of oxidized forms of MHC class I heavy chains, as
higher levels of reduced heavy chains were found in
PDI-depleted cells (13). However, the majority of TAP-
associated heavy chains were oxidized in PDI-depleted
cells (13), which suggests that PDI did not have a major
influence on maintaining oxidized forms of TAP-associated
heavy chains. The possibility of a function for TAP-
associated PDI in mediating tapasin oxidation is suggested
by the findings that TAP-associated forms of tapasin are
more oxidized compared with Pasta-1-associated forms
of tapasin (data not shown); however, the oxidized form
of tapasin found in complex with TAP may also simply
result from steric constraints of reductase access to TAP-
associated forms of tapasin, rather than PDI-dependent
catalytic oxidation. The relevant role of TAP-associated
PDI may relate to the sequestration of TAP-translocated
peptides, to prevent their premature retro-translocation,
as previously suggested (13,28). Alternatively, since the
presence of functional forms of TAP-associated tapasin
reduced the extent of PDI–TAP binding (Figures 6A,C), it
is also possible that PDI functions in the retro-translocation
and degradation of components of the TAP complex,
including TAP itself, when not stabilized by a complete
repertoire of associated factors. PDI binding to TAP may
involve interactions with surface hydrophobic patches on
PDI (27). Further functional studies will be needed to
assess whether TAP-associated PDI represents a specific
mechanism for mediating peptide retention in the ER, or
peptide loading complex (PLC) component degradation. It
is a formal possibility that the observed TAP–PDI complex
represents a more non-specific hydrophobic interactions-
based binding.
Our studies also allowed a direct assessment of the
effects of ERp57 and TAP binding on tapasin folding.
Abrogation of C95-mediated conjugate formation did not
induce significant soluble tapasin(C95A) aggregation in
cell lysates, and soluble tapasin(C95A) migrated predomi-
nantly as monomers (data not shown). However, soluble
wild-type tapasin was aggregated when purified from
cell supernatants, even when co-expressed with ERp57
(Figure 9A,D), suggesting that in addition to oxidoreduc-
tase binding, interactions with ER lumenal factors such as
calreticulin and GRP78 may be important for maintaining
tapasin stability and inhibiting its aggregation (Figure 9B).
In summary, we show that tapasin functions by two
major mechanisms, involving (i) binding of MHC class I
molecules via interactions involving its ER lumenal and
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transmembrane/cytosolic domains and (ii) recruitment of
ERp57 and calreticulin into the MHC class I assembly
complex (Figure 10). Further studies are required to
understand whether the tapasin transmembrane and
cytosolic domains directly impact tapasin–MHC class I
binding, or whether TAP/tapasin binding impacts the
efficiency of tapasin–MHC class I binding. Alternatively,
the transmembrane domain of tapasin could induce
binding merely by increasing the local concentrations of
tapasin in membranes containing MHC class I. In addition,
whether the ERp57-independent functional activity of
tapasin results in part from its ability to promote physical
interactions between MHC class I and TAP (thus achieving
a higher local concentration of peptides) also remains
to be investigated. Furthermore, modes of calreticulin
interaction and function remain to be defined, as also the
precise function of TAP-associated PDI.
Materials and Methods
Cell lines
M553 cells (obtained from Dr Naveen Bangia (16) and HeLa cells were
grown in RPMI 1640 and DMEM (Invitrogen), respectively, supplemented
with 10% FBS and penicillin–streptomycin. Chinese hamster ovary
(CHO) cells expressing tapasin or tapasin and ERp57 were grown in
alpha-MEM media (Invitrogen) supplemented with 5% dialyzed FBS and
antibiotics–antimycotics (Invitrogen).
Retroviral constructs
The construction of retroviral vectors encoding tapasin and influenza
hemagglutinin (HA)-tagged HLA-A2 has been previously described (22,29).
The C95A mutant of full-length tapasin was generated using the
QuikChange site-directed mutagenesis kit and full-length tapasin in
the pAcUW51 vector using the following oligonucleotides, 5-ACCCCC
GCGCAGAACGCCCCGCGGGCCCTGGAT-3 and 5-ATCCAGGGCCCGCGG
GGCGTTCTGCGCGGGGGT-3. Mutant clones were sequenced and ligated
into pMSCV-puro. The C95A mutant of soluble FLAG-tagged tapasin
was generated by site-directed mutagenesis of soluble tapasin in the
pBJ5-GS vector (10) using the oligonucleotides described above. Mutant
or wild-type soluble tapasin were sequenced and ligated into pMSCV-
puro. Viruses were generated as previously described (30,31) using BOSC
cells, and used to infect M553 cells. Retrovirus infectivity to human cells
was achieved by pseudotyping the retroviral envelope with the vesicular
stomatitis virus G protein. M553 cells were transduced with retroviruses
encoding HA-HLA-A2, and selected by treatment with 1 mg/mL Geneticin
(Invitrogen), and maintained in 0.5 mg/mL Geneticin (this cell line is
designated as M553/A2). After verifying M553/A2 expression by flow
cytometric analyses and by immunoblotting analyses of cell lysates, M553
or M553/A2 cells were transduced with the different tapasin-encoding
retroviruses, and selected by treatment with 1 μg/mL puromycin (Sigma).
Cells were maintained in 0.5 μg/mL puromycin.
Fluorescence-activated cell sorting analysis to assess
MHC class I cell surface expression
A total of 2 × 106 cells were washed 3× with fluorescence-activated
cell sorter (FACS) buffer (PBS pH 7.4 containing 1% FBS). Cells were
then incubated with anti-HA ascites (Covance Scientific) or W6/32 ascites
fluid (a human MHC class I heterodimer-specific antibody) (32) at a 1:250
dilution for 1 h on ice. Following this incubation, cells were washed 3×
with FACS buffer. Cells were then incubated for 1 h on ice with fluorescein
isothiocyanate (FITC)-conjugated goat anti-mouse immunoglobulin G (IgG)
(Jackson Laboratories) at 1:250 dilutions, followed by three washes with
FACS buffer. Cells were then analyzed using a FACS-Canto cytometer and
WINMDI software (Joe Trotter, The Scripps Institute, Flow Cytometry Core
Facility).
Immunoprecipitation and immunoblotting analysis
Three-six confluent 100 × 20 mm plates (4 × 106 cells per plate) of
M553/A2 or M553 cells expressing different tapasin constructs were
treated with 500 IU IFN-γ (PeproTech) for 48 h and processed for
different immunoprecipitation as described below. IFN-γ treatment of
cells was used to up-regulate TAP and promote TAP-mediated binding
interactions.
To study tapasin and MHC class I binding to various proteins (Figures 2
and 4), the IFN-γ-treated M553/A2 or M553 cells were harvested and
washed in PBS pH 7.4. The cells were then incubated with membrane-
permeable cross-linker (4 mM DTBP) in PBS pH 8.2 for 1 h at room
temperature followed by incubation with 1 M Tris pH 7.4 for 15 min
at room temperature to quench free cross-linker. The cells were then
washed once with PBS pH 7.4 and lysed in lysis buffer (25 mM Tris,
150 mM NaCl, 0.2 mM CaCl2, 1% digitonin and protease inhibitors) for
1 h on ice. The lysates were centrifuged at 4◦C for 30 min and protein
concentration in lysates was determined by a bicinchoninic acid (BCA)
protein assay (Pierce, Thermo Scientific). Equal microgram amounts of
lysates were incubated with anti-tapasin (Pasta-1; (6) obtained from Dr.
Peter Cresswell) or HC10 (33) overnight at 4◦C. Following overnight
incubation, immunoprecipitates were isolated with protein G beads for 2
h at 4◦C. The beads were washed three times with lysis buffer containing
0.1% digitonin, resuspended in reducing or non-reducing SDS-PAGE buffer
and boiled. The proteins were separated by SDS-PAGE and analyzed by
western blotting using the enhanced chemiluminescence (ECL) Plus Kit
(Amersham, GE Healthcare). Immunoblotting analyses of the Pasta-1 and
HC10-based immunoprecipitations were undertaken with the following
antibodies; rabbit anti-tapasin antisera (antisera generated against an
N-terminal peptide of tapasin) obtained from Dr Ted Hanson (Washington
University) the HC10 antibody (33) for MHC class I heavy chains, rabbit
polyclonal anti-ERp57 antibody (Santa Cruz Biotechnology, Inc.) and rabbit
polyclonal anti-calreticulin (Stressgen). The secondary antibodies used
were Peroxidase AffiniPure goat anti-rabbit IgG (heavy and light chain) or
Peroxidase AffiniPure goat anti-mouse IgG (heavy and light chain) (Jackson
ImmunoResearch Laboratories, Inc.).
TAP binding was analyzed both in the absence (M553 cells) and in the
presence (M553/A2 cells) of cross-linking agent. For these analyzes,
IFN-γ-treated M553 cells expressing different tapasin constructs were
harvested and washed in PBS pH 7.4. The cells were then lysed in
lysis buffer (25 mM Tris, 150 mM NaCl, 0.2 mM CaCl2, 1% digitonin and
protease inhibitors) for 1 h on ice. M553/A2 cells were first incubated
with 4 mM DTBP in PBS pH 8.2 for 1 h at room temperature. The
cells were then washed once with PBS pH 7.4 after quenching the free
cross-linker and lysed as described for the M553 cells. Lysates were
immunoprecipitated with anti-TAP1 antisera (34) obtained from Dr M. J.
Androlewicz (Lee Moffit Cancer Center) and processed as above. HeLa
cells were also processed for TAP1 immunoprecipitation as above. For anti-
TAP1 immunoprecipitations, the following antibodies were used: mouse
anti-TAP1 (SB05 212) or mouse anti-tapasin (35) obtained from Dr Soldano
Ferrone, HC10 (33) to detect MHC class I heavy chains, mouse anti-PDI
monoclonal antibody (Abcam), mouse anti-ERp57 monoclonal antibody
(Abcam), goat polyclonal anti-calreticulin (Santa Cruz). The secondary
antibodies used were Peroxidase AffiniPure goat anti-mouse IgG (heavy
and light chain) or Peroxidase AffiniPure bovine anti-goat IgG (heavy and
light chain) (Jackson ImmunoResearch Laboratories, Inc.).
Metabolic labeling and endo-glycosidase
H sensitivity
To study the rates of intracellular trafficking of MHC class I in M553 or
M553 cells expressing full-length tapasin(C95A), cells were pulsed with
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0.1 mCi [S35]methionine-cysteine and chased for 0, 30, 60 and 120 min.
The cells were then lysed in 1% digitonin, precleared for 2 h with protein
G beads and lysates were immunoprecipitated with W6/32 antibody. The
IPs were processed as described for other IPs and divided into two equal
aliquots. One set of aliquots were treated with Endo-H for 1 h at 37◦C.
Following Endo-H digestion, the samples were resolved by SDS–PAGE
and developed by phosphorimaging analysis.
Tapasin-oxidoreductase conjugate formations
(Figure 7)
For these analyses, IFN-γ-treated cells were harvested and incubated
with 2 mM MMTS (Pierce) in PBS pH 7.4 for 10 min on ice. MMTS was
used alone without DTBP. The cells were then pelleted and lysed in
lysis buffer containing 1% digitonin and 10 mM MMTS. Equal microgram
amounts of lysates were incubated with anti-tapasin (Pasta-1; (6) obtained
from Dr Peter Cresswell) overnight at 4◦C. Samples were processed for
immunoblotting analyses as described above.
Protein purifications (Figures 8 and 9)
Twelve confluent 100 × 20 mm plates of M553 cells expressing soluble
tapasin were harvested and washed with PBS pH 7.4. The cells were
lysed in lysis buffer (50 mM sodium phosphate, pH 7.0, 10 mM MMTS, 1%
Triton-X-100 and protease inhibitors) for 1 h on ice. MMTS was used alone
and not used in combination with DTBP. For CHO cell experiments, 20
confluent plates of CHO cells (100 × 20 mm) expressing tapasin or tapasin
and ERp57 were harvested and washed with PBS pH 7.4. The cells were
lysed as above. The lysates were centrifuged at 4◦C for 30 min and loaded
onto an anti-FLAG agarose column (Sigma). The column was washed with
50 mM sodium phosphate buffer containing 1% Triton-X-100 and 2 mM
MMTS, then with 50 mM sodium phosphate buffer alone, and proteins
eluted using FLAG peptide. Proteins were concentrated and separated
by gel filtration chromatography. Different fractions were analyzed for
the presence of tapasin, ERp57 and PDI by immunoblotting analyses. To
determine the relative amounts of PDI and ERp57 that were associated
with soluble tapasin following gel filtration analysis, two different methods
were used. The soluble tapasin conjugates or different amounts of
purified ERp57 and PDI proteins (ProSpec) were separated by SDS–PAGE
and immunoblotting analyses undertaken with anti-PDI (Santa Cruz
Biotechnology, Inc.) and anti-ERp57 (Santa Cruz Biotechnology, Inc).The
blots were scanned and relative band intensities were quantified using
IMAGEQUANT software. Signals for purified ERp57 and PDI were plotted as a
function of protein concentration, and analyzed by Prism to estimate the
amounts of ERp57 and PDI present in the conjugate fractions. In a second
analysis, the complexes were resolved by SDS–PAGE, Coomassie Blue
stained, and indicated bands excised and submitted for mass spectrometric
analyses. Relative amounts of each protein were estimated by comparing
average intensities of 10 most abundant peptides for each protein
(Figure S1).
For proteins purified from CHO cells, eluted proteins were separated by
SDS–PAGE, Coomassie Blue stained and indicated bands were subjected
to mass spectrometric analysis. All mass spectrometric analyses were
conducted at the Taplin Biological Mass Spectrometry Facility (Harvard
Medical School). Protein purifications from CHO cells supernatants were
undertaken as previously described (10).
Full-length human calreticulin (hCRT) lacking the signal sequence was
generated using ligation-independent cloning (LIC). The sequence was
amplified by polymerase chain reaction (PCR) using primers that allowed
for subsequent LIC into the pMCSG7 vector. The following oligonu-
cleotide primers were used; Forward: 5′ TACTTCCAATCCAATGCTGTCGC-
CGAGCCTGC 3′ and Reverse: 5′ TTATCCACTTCCAATGTTACAGCTCGTC-
CTTGGC 3′ The purified constructs contain an N-terminal MHHHHHHSS-
GVDLGTENLYFQSNA fusion sequence. The protein was induced at room
temperature overnight and purified using nickel beads according to the
standard protocol. The protein was further purified by gel filtration column
and stored at −20◦C in 10% glycerol.
Expression of tapasin and ERp57 in CHO cells
ERp57 lacking the ER retention sequence was amplified using the
following oligonucleotides: 5-AAGCGGCCGCCAGCTGCCACCATGCGCC
TCCGCCGC-3 and 5-ATGCGGCCGCGGTACCTTATGCCTTCTTCTTCTT-3
and cloned into the pBJ5GS vector using BamHI and Not1 sites. CHO
cells were transfected with pBJ5-GS vector expressing tapasin and
ERp57 by the lipofectin protocol and cells were selected with methionine
sulfoximine as previously described (10). Clones surviving selection were
screened for expression of tapasin and ERp57 by immunoprecipitations
of cell supernatants with anti-FLAG (Sigma) and anti-ERp57 monoclonal
antibody (Abcam) antibodies, following metabolic labeling of cells (10).
Cells expressing both proteins were clonally amplified, and clones re-
tested for expression of both proteins by metabolic labeling and co-
immunoprecipitation analyses, prior to large-scale amplification and protein
purifications as described above.
ELISA procedures
For these assays, tapasin was purified from lysates of CHO cells under
three different conditions (i) CHO–tapasin cells lysed in the absence of
MMTS (ii) CHO–tapasin cells lysed in the presence of MMTS or (iii)
CHO–tapasin–ERp57 cells lysed in the presence of MMTS. An anti-FLAG
column was used for purifying protein under each condition, as described
above. The protein concentrations were estimated by a BCA assay. The
ELISA plates (BD Falcon) were coated by overnight incubation at 4◦C with
1–2 μg of each type of tapasin, or BSA in PBS pH 7.4. Unbound proteins
were removed by washing the wells 3× with ELISA buffer (50 mM Tris,
150 mM NaCl, 0.5 mM CaCl2) containing 0.5% Tween-20 (Sigma). The wells
were blocked with 10% FBS in ELISA buffer at 37◦C for 1 h and excess FBS
was removed. To study calreticulin binding to tapasin, 1–2 μg of human cal-
reticulin in ELISA buffer was added and plates were incubated at 37◦C for
3 h. Unbound calreticulin was removed, anti-calreticulin antibody (goat anti-
calreticulin) was added and plates incubated at 37◦ C for 1 h. The primary
antibody was washed, secondary antibody (bovine anti-goat horseradish
peroxidase) added, prior to further incubation at 37◦C for 1 h. After wash-
ing the wells three times with ELISA buffer containing 0.5% Tween-20,
developer solution (BD Falcon) was added. The developer reaction was
stopped by adding 2 N H2SO4 and absorbance read at 450 nm.
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Additional Supporting Information may be found in the online version of
this article:
Figure S1: Association of ERp57 and PDI with soluble tapasin in M553
cells. A total of 4.8 × 107 M553/soluble tapasin cells were lysed in the
presence of MMTS (no cross-linker) and immunoprecipitated with anti-
FLAG beads. The anti-FLAG eluates were run on a gel filtration column
to isolate soluble tapasin and associated proteins. Gel filtration fractions
containing ERp57/PDI and soluble tapasin were concentrated, protein
separated by SDS–PAGE and Coomassie Blue staining, and indicated
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bands (Figure 8B) were subjected to mass spectroscopic analysis. The
most abundant proteins identified in band 2 (Figure 8B) were ERp57 and
PDI. The bar graphs show 10 of the most abundant peptides identified for
ERp57 (A) and PDI (B). The NL (relative peptide abundance) values of top
10 peptides were used to estimate the relative amounts of each protein
associated with soluble tapasin.
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